Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Journal of Diabetes & Metabolic Disorders
Published in: Journal of Diabetes & Metabolic Disorders 1/2014

Open Access 01-12-2014 | Case report

Diabetic muscle infarction and diabetic dermopathy two manifestations of uncontrolled prolong diabetes mellitus presenting with severe leg pain and leg skin lesions

Authors: Saeedeh Shenavandeh, Amir Anushiravani, Mohammad Ali Nazarinia

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2014

Login to get access

Abstract

Diabetic muscular infarction (DMI) is a rare manifestation which can be seen in patients with long-standing diabetes mellitus. Patients usually come with painful swelling of an involved muscle in one extremity. MRI and biopsy histology can help diagnose this condition. Diabetic dermopathy is another manifestation of patients with diabetes.
We present a patient with uncontrolled diabetes type 2 presented with pain, swelling, and a palpable tender mass in one leg along with new skin lesions. Biopsy of the skin lesion and T2-weighted MRI of the leg helped differentiate DMI and dermopathy.
Appendix
Available only for authorised users
Literature
1.
Iyer SN, Drake AJ, West RL, Tanenberg RJ: Diabetic Muscle Infarction: a rare complication of long-standing and poorly controlled diabetes mellitus. Case Rep Med 2011, 2011: 407921.CrossRefPubMedPubMedCentral
2.
Lafforgue P, Janand-Delenne B, Lassman-Vague V, Daumen-Legre V, Pham T, Vague P: Painful swelling of the thigh in a diabetic patient: diabetic muscle infarction. Diabetes Metab 1999, 25: 255–260.PubMed
3.
Scully RE, Mark EJ, McNelly WF, Ebeling SH, Phillips LD: Case 29: case records of the Massachusetts General Hospital. N Engl J Med 1997, 337: 839–845. 10.1056/NEJM199709183371208
4.
5.
Cardillo S, Huse JT, Iqbal N: Diabetic muscle infarctionof the forearm in a patient with long-standing type 1 diabetes. Endocr Pract 2006, 12: 188–192. 10.4158/EP.12.2.188CrossRefPubMed
6.
Anglada M, Vidaller A, Bolao F, Ferrer I, Olive’ M: Diabetic muscle infarction. Muscle Nerve 2000, 23: 825–826. 10.1002/(SICI)1097-4598(200005)23:5<825::AID-MUS25>3.0.CO;2-ICrossRefPubMed
7.
Chester CS, Banker BQ: Focal infarction of muscle in diabetics. Diabetes Care 1986, 9: 623–630. 10.2337/diacare.9.6.623CrossRefPubMed
8.
Jelinek JS, Murphey MD, Aboulafia AJ, Dussault RG, Kaplan PA, Snearly WN: Muscle infarction in patients with diabetes mellitus: MR imaging findings. Radiology 1999, 211: 241–247. 10.1148/radiology.211.1.r99ap44241CrossRefPubMed
9.
Rocca PV, Alloway JA, Nashel DJ: Diabetic muscular infarction. Semin Arthritis Rheum 1993, 22: 280–287. 10.1016/0049-0172(93)80076-RCrossRefPubMed
10.
Powers AC: Diabetes Mellitus. In Harrison’s Principles of Internal Medicine, Volume 2. 18th edition. Edited by: Longo D, Fauci A, Kasper D, Hauser S, Jameson J. New York: McGraw-Hill; 2012:2988.
Metadata
Title
Diabetic muscle infarction and diabetic dermopathy two manifestations of uncontrolled prolong diabetes mellitus presenting with severe leg pain and leg skin lesions
Authors
Saeedeh Shenavandeh
Amir Anushiravani
Mohammad Ali Nazarinia
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2014
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1186/2251-6581-13-38

Other articles of this Issue 1/2014

Journal of Diabetes & Metabolic Disorders 1/2014 Go to the issue

Research article

A cross-sectional assessment to detect type 2 diabetes with endothelial and autonomic nervous system markers using a novel system

Erratum

Erratum to: Cross-country differences in the association between diabetes and disability

Review article

Metals in the pathogenesis of type 2 diabetes

Research article

Prevalence of metabolic syndrome and its correlated factors among children and adolescents of Ahvaz aged 10 – 19

Research article

Tibia bone properties at different time course of ovariectomized rats

Research article

Implementation of Ramadan-specific diabetes management recommendations: a multi-centered prospective study from Pakistan
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits